FDA publishes more than 200 archived CRLs for transparency
The FDA has issued more than 200 complete response letters, which detail reasons...
EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma
BeOne Medicines has secured approval from the EC for Tevimbra (tislelizumab) to ...
Merck agrees to acquire Verona Pharma for $10bn
Merck has entered a definitive agreement to acquire biopharmaceutical company Ve...